Tags: Clinical Safety,News
Advisory post relating to notification issued by Pfizer Ltd of interruption in supply of the 2-pack of Vydura® (rimegepant) in the UK w/c 12th January 2026
Tags: Clinical Safety
Clinical safety advisory blog post - prescribing of Rybelsus ® tablets where both original and new formulations are available on the market.
Tags: Clinical Safety,Vision 3
Clinical safety advisory post relating to an issue affecting the Vision 3 immunisations form - Stage 1 Due Date not clearing when changing to Stage 2.
Advice and guidance to GP surgeries relating to CHI changes being implemented by Practitioner Services Division (PSD) from 1st February 2026
Clinical advisory post relating to pregnancy / breast-feeding related prescribing decision support warnings possibly not displaying accurately in Vision
Tags: Clinical Safety,Vision 3
Advice and guidance to GP surgeries relating to an issue affecting some acute prescription requests made using Vision Patient Facing Services
Advisory post relating to issue with Vision+ QRISK2 calculator.
Tags: Clinical Safety,Vision 3
Advisory information re: Vision 3 prescribing functionality that results in 'Additional Instructions' being cleared when a CMS item is changed to a repeat
Clinical safety advisory post relating to an issue affecting Vision Anywhere where the repeat medication section of patient records is presented as blank.
Advice and guidance to GP surgeries relating to how to appropriately record a Penicillin drug allergy in Vision